Human Immunodeficiency Virus (HIV)  
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for HIV trials.

Effective solutions for advancing HIV research

Human Immunodeficiency Virus (HIV)-1 infection is a life-threatening disease affecting approximately 37 million people worldwide. Advances in antiretroviral therapies (ART) are improving the quality of life for people living with HIV (PLWHIV) by suppressing viral replication, preserving immunologic function, and preventing the disease from progressing.

Why Signant Health

  • Achieve Optimal Adherence
  • Educate People Living with HIV
  • Provide Flexible Participation Options
  • Simplify Data Collection
  • Make Participation Easier
  • Digitalize the Entire Study
  • Achieve Optimal Adherence

    Achieve Optimal Adherence

    The Randomization & Trial Supply Management (RTSM) solution ensures the right medication reaches people living with HIV at the right time to prevent detrimental interruptions in therapy.

  • Educate People Living with HIV

    Educate People Living With HIV

    Signant’s eConsent ensures consent forms are completed with the correct IRB- or IEC-approved form. Capable of supporting various learning styles, our tiered eConsent solutions use engaging multimedia to educate PLWHIV on study participation.

  • Provide Flexible Participation Options

    Provide Flexible Participation Options

    Telemedicine can replace in-person visits with convenient video consultations, reducing travel burdens for participants and allowing sponsors to reach more diverse populations.

  • Simplify Data Collection

    Simplify Data Collection

    Our Signant SmartSignals eCOA contains disease-specific questionnaires that assess the effect of treatment on quality of life and various functions. The digital format eliminates the need to transcribe from paper and provides time-stamped, attributable data.

  • Make Participation Easier

    Make Participation Easier

    Patient Concierge, a module of Signant SmartSignals eCOA, improves communication between PLWHIV and site staff through helpful reminders and easily accessible visit information.

  • Digitalize the Entire Study

    Digitalize the Entire Study

    All the Signant SmartSignals solutions can be used as standalone tools or integrated with one another to further enhance the accuracy and efficiency of your HIV study.

Comprehensive HIV experience

0

TRIALS

0

COUNTRIES

0

PATIENTS

0

SITES

Explore our HIV trial resources
SOLUTION BROCHURE

HIV Trial Solutions Overview

GET INSIGHTS
VIDEO

HIV Trial Solutions

WATCH [2 MIN]
SOLUTION

Vaccine Clinical Trial Solutions

LEARN MORE

Ready to learn more?

Discover how Signant can support your current or upcoming HIV trials.